Attributes | Values |
---|
rdf:type
| |
description
| - wetenschappelijk artikel (nl)
- scientific article published on 01 July 2019 (en)
- artículu científicu espublizáu en xunetu de 2019 (ast)
- наукова стаття, опублікована 1 липня 2019 (uk)
|
publication date
| |
publication date
| |
author name string
| |
author name string
| - Marco W J Schreurs
- Marjan A Versnel
- P Martin van Hagen
- Matti Waris
- Sylvia Kamphuis
- Paul L A van Daele
- Virgil A S H Dalm
- Cornelia G van Helden-Meeuwsen
- Jan A M van Laar
- Erika Huijser
- Iris L A Bodewes
- M Javad Wahadat
|
rdfs:label
| - MxA is a clinically applicable biomarker for type I interferon activation in systemic lupus erythematosus and systemic sclerosis (en)
- MxA is a clinically applicable biomarker for type I interferon activation in systemic lupus erythematosus and systemic sclerosis (nl)
|
skos:prefLabel
| - MxA is a clinically applicable biomarker for type I interferon activation in systemic lupus erythematosus and systemic sclerosis (en)
- MxA is a clinically applicable biomarker for type I interferon activation in systemic lupus erythematosus and systemic sclerosis (nl)
|
name
| - MxA is a clinically applicable biomarker for type I interferon activation in systemic lupus erythematosus and systemic sclerosis (en)
- MxA is a clinically applicable biomarker for type I interferon activation in systemic lupus erythematosus and systemic sclerosis (nl)
|
author
| |
author
| |
title
| |
title
| - MxA is a clinically applicable biomarker for type I interferon activation in systemic lupus erythematosus and systemic sclerosis (en)
|
page(s)
| |
page(s)
| |
instance of
| |
instance of
| |
main subject
| |
main subject
| |
PubMed ID
| |
PubMed ID
| |
PubMed ID
| |
published in
| |
published in
| |
issue
| |
volume
| |
issue
| |
volume
| |
DOI
| |
DOI
| |
DOI
| - 10.1093/RHEUMATOLOGY/KEZ078
|
is about
of | |
is cites work
of | |
is cites work
of | |